Since, PLK4 depletion leads to a substantial decrease of breast cancer cells’ invasiveness into surrounding tissues in vivo [99], it is plausible that these effects are modulated by PLK4’s regulation of EMT [100]. The gene discussed is PLK4; the disease is breast carcinoma.